Avelumab Interactions
There are 407 drugs known to interact with avelumab, along with 10 disease interactions. Of the total drug interactions, 3 are major, and 404 are moderate.
- View all 407 medications that may interact with avelumab
- View avelumab disease interactions (10)
Most frequently checked interactions
View interaction reports for avelumab and the medicines listed below.
- Abraxane (paclitaxel protein-bound)
- Adriamycin (doxorubicin)
- Akynzeo (netupitant / palonosetron)
- Aloxi (palonosetron)
- Ampyra (dalfampridine)
- Avastin (bevacizumab)
- Benefiber Powder (wheat dextrin)
- Bystolic (nebivolol)
- Calcium 600+D Plus Minerals (multivitamin with minerals)
- CoQ10 (ubiquinone)
- Cymbalta (duloxetine)
- Eliquis (apixaban)
- Fetzima (levomilnacipran)
- Focalin (dexmethylphenidate)
- Focalin XR (dexmethylphenidate)
- Gammagard S/D (immune globulin intravenous)
- Januvia (sitagliptin)
- Lasix (furosemide)
- Lyrica (pregabalin)
- Maxzide (hydrochlorothiazide / triamterene)
- Medrol Dosepak (methylprednisolone)
- Metamucil Orange Smooth Texture Sugar Free (psyllium)
- MiraLAX (polyethylene glycol 3350)
- Morphine Sulfate ER (morphine)
- Neulasta (pegfilgrastim)
- Phenergan (promethazine)
- Prilosec (omeprazole)
- Protonix (pantoprazole)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Avelumab disease interactions
There are 10 disease interactions with avelumab which include:
- hepatic impairment
- adrenal insufficiency
- colitis
- diabetes
- pneumonitis
- renal dysfunction
- thyroid disease
- HSCT
- myasthenia gravis
- organ transplant
Report options
QR code containing a link to this page
More about avelumab
- avelumab consumer information
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
